1. Tumour-expressed tissue factor inhibits cellular cytotoxicity

   • Chao Li
   • Lucy M. Colman
   • Camille Ettelaie

   Original Article 02 February 2006 Pages: 1301 - 1308

   

2. Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12

   • Chang-Hyun Kim
   • Min-Jung Hong
   • Yong-Kil Hong

   Original Article 04 February 2006 Pages: 1309 - 1319

   

3. Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer

   • Toru Nakanishi
   • Kazuyoshi Imaizumi
   • Kaoru Shimokata

   Original Article 02 February 2006 Pages: 1320 - 1329

   

4. Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice

   • Ali Abdul-Hai
   • Arie Ben-Yehuda
   • Reuven Or

   Original Article 01 February 2006 Pages: 1330 - 1336

   

5. PankoMab: a potent new generation anti-tumour MUC1 antibody

   • Antje Danielczyk
   • Renate Stahn
   • Steffen Goletz

   Original Article 17 February 2006 Pages: 1337 - 1347

   

6. Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells

   • Roi Avraham
   • Shelly Inbar
   • Shamgar Ben-Eliyahu

   Original Article 08 February 2006 Pages: 1348 - 1357

   

7. Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs

   • Kousaku Mimura
   • Koji Kono
   • Hideki Fujii

   Original Article 25 January 2006 Pages: 1358 - 1366

   

8. A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells

   • P. Wolf
   • D. Gierschner
   • U. Elsässer-Beile

   Original Article 18 March 2006 Pages: 1367 - 1373

   

9. Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate

   • Thomas Putz
   • Reinhold Ramoner
   • Martin Thurnher

   Original Article 17 February 2006 Pages: 1374 - 1383

   

10. Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells

    • Cheryl L.-L. Chiang
    • Jonathan A. Ledermann
    • Benjamin M. Chain

    Original Article 04 February 2006 Pages: 1384 - 1395

    

11. Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI)

    • Jan Schmidt
    • Emilia M. Patrut
    • Angela Märten

    Original Article 17 February 2006 Pages: 1396 - 1405

    

12. International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

    • Barbara-ann Guinn
    • James S. Norris
    • Albert B. Deisseroth

    Symposium Paper 17 June 2006 Pages: 1406 - 1411

13. Targeted and shielded adenovectors for cancer therapy

    • Susan J. Hedley
    • Jian Chen
    • Imre Kovesdi

    Symposium Paper 13 April 2006 Pages: 1412 - 1419

    

14. Virology- and immunology-based gene therapy for cancer

    • Masatoshi Tagawa
    • Kiyoko Kawamura
    • Takenori Ochiai

    Symposium Paper 12 May 2006 Pages: 1420 - 1425

    

15. Immune enhancement and anti-tumour activity of IL-23

    • Jing-Sheng Hao
    • Bao-En Shan

    Symposium Paper 05 May 2006 Pages: 1426 - 1431

    

16. Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells

    • Jon A. Kyte
    • Gustav Gaudernack

    Symposium Paper 13 April 2006 Pages: 1432 - 1442

    

17. Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease

    • M. Tangney
    • G. Casey
    • G. C. O’Sullivan

    Symposium Paper 13 April 2006 Pages: 1443 - 1450